SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-20-002838
Filing Date
2020-04-24
Accepted
2020-04-24 07:00:20
Documents
4
Period of Report
2020-06-02
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_042420.htm DEF 14A 420446
2 GRAPHIC logo.jpg GRAPHIC 14054
3 GRAPHIC pcard_1.jpg GRAPHIC 1864703
4 GRAPHIC pcard_2.jpg GRAPHIC 1381615
  Complete submission text file 0001171843-20-002838.txt   4908071
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32001 | Film No.: 20812459
SIC: 2836 Biological Products, (No Diagnostic Substances)